Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Cancer Center Selected as Melanoma Center of Excellence
PHILADELPHIA (October 14, 2020)—Fox Chase Cancer Center has been selected as the newest institution in The Melanoma Research Foundation Breakthrough Consortium (MRFBC).
Founded in 2010, the MRFBC is a nationwide network of 21 centers of excellence in melanoma united to accelerate research and development of the most promising melanoma treatments. The MRF is the largest independent organization devoted to melanoma.
“Our melanoma program at Fox Chase is thrilled to be joining the Melanoma Research Foundation Breakthrough Consortium,” said Jeffrey M. Farma, MD, FACS, co-director of the Melanoma and Skin Cancer Program and professor in the Department of Surgical Oncology.
“This partnership will allow for increased research collaborations with world experts in melanoma to continue to make strides in discoveries with hopes to improve the quality of life and cure patients with melanoma,” he added.
“The MRF eagerly welcomes Fox Chase Cancer Center as the newest member of its Breakthrough Consortium,” said MRF CEO Kyleigh LiPira, MBA. “Under the leadership of Dr. Farma, we anticipate Fox Chase to be an engaged and collaborative member site and a valued addition to this important research initiative.”
She added that MRF has proudly supported the innovative research conducted at Fox Chase for many years and is confident this expanded partnership will produce even greater results and new breakthroughs for the melanoma community.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427